Effectiveness of Dry Needling Versus Cupping Therapy for Pain in Piriformis Syndrome

NCT06437795 | Active Not Recruiting DMC

• 1 other identifier: MSRSW/Batch-Fall22/715
• Study Type: interventional
• Target: 80
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to compare the effectiveness of two popular therapeutic interventions, dry needling and cupping therapy, in alleviating pain associated with Piriformis Syndrome. Piriformis Syndrome is a neuromuscular disorder caused by the compression or irritation of the sciatic nerve by the piriformis muscle, leading to buttock pain and radiating numbness.

Conditions

Piriformis Syndrome

Outcome Measures

Primary Outcomes (2)

• Visual Analog Scale (VAS)

  Participants will rate their pain on a scale from 0 (no pain) to 10 (worst possible pain) at the beginning and end of the study.

  12 Months

• Oswestry Disability Index (ODI)

  This tool assesses the degree of disability in performing daily activities. Quality of life improvements measured by the SF-36 Health Survey, which evaluates physical and mental health status.

  12 months

Study Arms (2)

Dry Needling Group

EXPERIMENTAL

Diagnostic Test: Dry Needling Group

Cupping Therapy Group

OTHER

Other: Cupping Therapy Group

Interventions

Dry Needling Group DIAGNOSTIC_TEST

Participants in this group will receive dry needling therapy. This involves inserting thin needles into trigger points in the piriformis muscle to relieve pain and muscle tension. The therapy will be administered twice a week for 4 weeks, with each session lasting approximately 30 minutes.

Dry Needling Group

Cupping Therapy Group OTHER

Participants in this group will receive cupping therapy. This involves placing cups on the skin to create suction, which is believed to improve blood flow and reduce muscle tension. The therapy will be administered twice a week for 4 weeks, with each session lasting approximately 30 minutes.

Cupping Therapy Group

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Adults aged between 18 to 65 years.
• Diagnosed with piriformis syndrome.
• Experiencing chronic pain for at least 3 months.
• Willingness to comply with the study protocol and attend all therapy sessions.

You may not qualify if:

• Recent surgery on the lower back or hip.
• Presence of systemic diseases affecting muscle function (e.g., multiple sclerosis, rheumatoid arthritis).
• Pregnant or breastfeeding women.
• Use of anticoagulant medication or having a bleeding disorder.
• Participating in another clinical trial simultaneously

Sponsors & Collaborators

• Superior University: lead

Study Sites (1)

Ghurkee Hospital

Lahore, Punjab Province, Pakistan

Location

MeSH Terms

Conditions

Piriformis Muscle Syndrome

Condition Hierarchy (Ancestors)

Sciatic Neuropathy; Mononeuropathies; Peripheral Nervous System Diseases; Neuromuscular Diseases; Nervous System Diseases; Nerve Compression Syndromes; Neuralgia; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Pelvic Pain

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: May 25, 2024
• First Posted: May 31, 2024
• Study Start: November 1, 2023
• Primary Completion: May 1, 2024
• Study Completion: September 1, 2024
• Last Updated: May 31, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

PA (1)